77Port Tuesday, 04/16/19 03:24:04 PM Re: Full Contact Yoga post# 4053 Post # of 4057 I don't disagree that they are expert 3-Card Monty players, always hiding the card by keeping it moving. They seem to put all the money back into the science and, over the long run, that's not a bad thing. But if you're an investor wanting a payout, it sucks. Today's release had this paragraph and, if it happens as they hope, this technique may be a player in the world of cancer treatment. Precision Therapeutics’ Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Today : Tuesday 16 April 2019 “The TumorGenesis platform and its methodology for tagging a tumor’s diverse cancer cell population is highly complementary to our Helomics discovery service business, which utilizes AI (Artificial Intelligence) and tumor genetic and drug response profiling. Our vision is to tag every patient’s complex tumor cell populations first with biomarkers, then to separate cancer cells using those biomarkers, creating a unique ‘fingerprint’ of that tumor to deliver a personalized medicine approach to cancer diagnosis and treatment,” said Dr. Carl Schwartz, CEO of Precision Therapeutics, Inc.